Trials / Completed
CompletedNCT00451932
A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients
A Multicentre, Randomised, Double-Blind, Tacrolimus Dual Therapy-Controlled, Parallel Group, Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of FK778 in Liver Transplant Patients Receiving Standard Tacrolimus (FK506) and Steroids Therapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 303 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A proof of concept study to evaluate the safety and effectiveness of FK778 in liver transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FK778 |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2005-09-01
- Completion
- 2005-09-01
- First posted
- 2007-03-26
- Last updated
- 2008-04-17
Locations
29 sites across 12 countries: Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Netherlands, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00451932. Inclusion in this directory is not an endorsement.